Decathlon has developed kneeMID500-STRONG700 products which are two medical devices designed to be used for sport resumption after mild (kneeMID500) or moderate (KneeSTRONG100) knee sprain or after an Anterior Cruciate Ligament surgery. The difference between these devices is based on the strength of compression and the knee maintain. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon kneeMID500-STRONG700 products to demonstrate safety and performance of these devices in a real-world setting.
Study Type
OBSERVATIONAL
Enrollment
60
At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) per device type (2 device types: Knee MID 500 and Knee STRONG 700) totalling 60 patients will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use a knee support device.
Centre de rééducation et de balnéothérapie Kinés Faches
Faches-Thumesnil, France
RECRUITINGCentre Hospitalier Universitaire de Lille
Lille, France
RECRUITINGFunctional score
Comparison of the functional result (Lysholm Score: 0-100 points ; Tegner Activity Scale: 11-level gradient) between the baseline and last follow-up visit in each group (orthosis vs control), for each device model
Time frame: At baseline and 18 weeks of follow-up
Confidence level
Gap in the confidence level (patient rated outcome with 6 questions, ranging from 0 to 100) related to physical activity, between the baseline and last follow-up visit in each group (orthosis vs control), for each device model
Time frame: At baseline and 18 weeks of follow-up
Knee instability
Comparison of knee instability, assessed through a numerical rating scale (NRS, ranging from 0 to 10), between the groups (orthosis vs control), for each device model
Time frame: At 6 weeks, 12 weeks and 18 weeks of follow-up
Knee pain
Comparison of knee pain, assessed through NRS (ranging from 0 to 10), between the groups (orthosis vs control), for each device model
Time frame: At 6 weeks, 12 weeks and 18 weeks of follow-up
Safety (adverse events)
Comparison of adverse events rates between the groups (orthosis vs control), for each device model
Time frame: 18 weeks of follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.